Platelet-related parameters at initial diagnosis for predicting the risk of chronicity in children with newly diagnosed immune thrombocytopenia

• by Shuxian Zheng, Jing Liang, Wen Jiang, Ran Han, Xiaofei Guo

• June 1, 2026

This Week’s CGT News: New FDA Genome Editing Guidance 

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

• April 20, 2026

• 6 min

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS

• by Caihong Qu, Xiaoying Wang

• May 1, 2026

Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis

• by Ally Sarna, Aya Finkelstein, Caroline Malcolmson, Renee Potashner, Natalie Pitch, Alessia Forestieri, Marilyn Cooper, Yuquing Feng, Aryan Patel, Tal Schechter, Karim Jessa, Lillian Sung, Adam P Yan

• May 15, 2026